TARS·87650L103·US·equity·Healthcare - Biotechnology-13D/G
TARS (TARSUS PHARMACEUTICALS INC) is held by 139 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($249.2M), RTW INVESTMENTS, LP ($234.7M), JANUS HENDERSON GROUP PLC ($157.2M). Net institutional sentiment: Mixed.
See how TARS's score breaks down across 4 SEC sources
Showing 1-20 of 150
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer